Technology
Health
Pharmaceutical

Teligent

$1.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-6.90%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Teligent and other stocks, options, ETFs, and crypto commission-free!

About

Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. Read More The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.

Employees
183
Headquarters
Buena, New Jersey
Founded
1977
Market Cap
62.37M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
460.71K
High Today
$1.24
Low Today
$1.07
Open Price
$1.21
Volume
205.66K
52 Week High
$4.52
52 Week Low
$1.07

Collections

Technology
Health
Pharmaceutical
Manufacturing
2015 IPO
US
North America

News

MarketWatchMar 19

Teligent Inc. Stock Quote (U.S.: Nasdaq)

Shares of Teligent, Inc. shot up 12% in premarket trade Thursday after the company announced the U.S. Food and Drug Administration had approved the company's abbreviated new drug application for a generic 0.05% solution of clobetasol propionate ointment, a topical steroid used to treat skin irritation. The company said it plans to launch the product sometime this month and that the total addressable market for the product is approximately $70.5 million, according to data from November from IQVIA . Shares of...

219
Seeking AlphaMar 18

Teligent, Inc. (TLGT) CEO Jason Grenfell-Gardner on Q4 2018 Results - Earnings Call Transcript

Teligent, Inc. (NASDAQ:TLGT) Q4 2018 Earnings Conference Call March 18, 2019 8:00 AM ET Company Participants Jason Grenfell-Gardner - President and CEO Damian Finio - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Elliot Wilbur - Raymond James Operator Good day, ladies and gentlemen, and welcome to the Teligent, Incorporated Fourth Quarter 2018 Results Conference Call. [Operator Instructions] As a reminder, this conference call maybe recorded. Except for historical facts, the s...

11
Seeking AlphaMar 18

Teligent down 14% on Q4 results

Teligent (TLGT) Q4 results: Revenues: $16.8M (+13.5%). Net Loss: ($14.4M) (-136.1%); Loss Per Share: ($0.27) (-145.5%); Non-GAAP Loss Per Share: ($0.18) (200.0%); Non-GAAP Net Loss: ($9.8M). 2019 Guidance: Revenue: double digit top line percentage growth with revenues in excess of $72.5M....

70

Earnings

-$0.20
-$0.12
-$0.05
$0.03
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.03 per share
Actual
-$0.18 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.